Neuroprotective mechanisms of 3-n-butylphthalide in neurodegenerative diseases

Since 3-n-butylphthalide (NBP) was approved by the China Food and Drug Administration for the treatment of acute ischemia stroke in 2002, a number of studies have investigated NBP worldwide. In recent years, NBP has also demonstrated potential as treatment of several neurodegenerative diseases, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rixin, Wangqin, Runqi, Zhu, Lihong, Bi, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873419/
https://www.ncbi.nlm.nih.gov/pubmed/31798868
http://dx.doi.org/10.3892/br.2019.1246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873419/
https://www.ncbi.nlm.nih.gov/pubmed/31798868
http://dx.doi.org/10.3892/br.2019.1246

Ejemplares similares